Page last updated: 2024-10-24

busulfan and Bronze Diabetes

busulfan has been researched along with Bronze Diabetes in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Busulfan is a commonly used chemotherapeutic agent in myeloablative conditioning regimens for allogeneic hematopoietic cell transplantation (allo-HCT)."5.42Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning. ( Boyer, MW; Chen, S; Chen, X; Hildebrandt, GC; McDonald, GB; Osborn, JD, 2015)
"Busulfan is a commonly used chemotherapeutic agent in myeloablative conditioning regimens for allogeneic hematopoietic cell transplantation (allo-HCT)."1.42Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning. ( Boyer, MW; Chen, S; Chen, X; Hildebrandt, GC; McDonald, GB; Osborn, JD, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, S1
Osborn, JD1
Chen, X1
Boyer, MW1
McDonald, GB1
Hildebrandt, GC1

Other Studies

1 other study available for busulfan and Bronze Diabetes

ArticleYear
Subacute hepatic necrosis mimicking veno-occlusive disease in a patient with HFE H63D homozygosity after allogeneic hematopoietic cell transplantation with busulfan conditioning.
    International journal of hematology, 2015, Volume: 102, Issue:6

    Topics: Acute Disease; Adult; Allografts; Busulfan; Diagnosis, Differential; Hematopoietic Stem Cell Transpl

2015